BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29437755)

  • 1. A diagnostic cohort study on the accuracy of 18-fluorodeoxyglucose (
    Proli C; De Sousa P; Jordan S; Anikin V; Devaraj A; Love SM; Shackcloth M; Kostoulas N; Papagiannopoulos K; Haqzad Y; Loubani M; Sellitri F; Granato F; Bush A; Marchbank A; Iyer S; Scarci M; Lim E;
    BMJ Open; 2018 Feb; 8(2):e019471. PubMed ID: 29437755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
    El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence.
    El-Bawab HY; Abouzied MM; Rafay MA; Hajjar WM; Saleh WM; Alkattan KM
    Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):395-9. PubMed ID: 20639307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET parameters predicting mediastinal malignancy in lung cancer.
    Serra Fortuny M; Gallego M; Berna L; Montón C; Vigil L; Masdeu MJ; Fernández-Villar A; Botana MI; Cordovilla R; García-Luján R; Cases E; Monsó E
    BMC Pulm Med; 2016 Dec; 16(1):177. PubMed ID: 27931198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma.
    Byrd CT; Trope WL; Bhandari P; Konsker HB; Moradi F; Lui NS; Liou DZ; Backhus LM; Berry MF; Shrager JB
    J Thorac Cardiovasc Surg; 2023 Jan; 165(1):371-381.e1. PubMed ID: 35568521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses.
    Luzzi L; Campione A; Gorla A; Vassallo G; Bianchi A; Biggi A; Terzi A
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):475-9. PubMed ID: 19501523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Usefulness of Positron-Emission Tomography Findings in the Management of Anterior Mediastinal Tumors.
    Kitami A; Sano F; Ohashi S; Suzuki K; Uematsu S; Suzuki T; Kadokura M
    Ann Thorac Cardiovasc Surg; 2017 Feb; 23(1):26-30. PubMed ID: 28123154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
    Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S
    Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
    Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT.
    Yabuuchi H; Matsuo Y; Abe K; Baba S; Sunami S; Kamitani T; Yonezawa M; Yamasaki Y; Kawanami S; Nagao M; Okamoto T; Nakamura K; Yamamoto H; Sasaki M; Honda H
    Clin Radiol; 2015 Nov; 70(11):1289-98. PubMed ID: 26272529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning.
    Travaini LL; Petralia G; Trifirò G; Ravasi L; Galetta D; Carbone G; Falcini F; Spaggiari L; Bellomi M; Paganelli G
    Lung Cancer; 2008 Sep; 61(3):362-8. PubMed ID: 18358558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.
    Eubank WB; Mankoff DA; Takasugi J; Vesselle H; Eary JF; Shanley TJ; Gralow JR; Charlop A; Ellis GK; Lindsley KL; Austin-Seymour MM; Funkhouser CP; Livingston RB
    J Clin Oncol; 2001 Aug; 19(15):3516-23. PubMed ID: 11481358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest.
    Bangerter M; Kotzerke J; Griesshammer M; Elsner K; Reske SN; Bergmann L
    Acta Oncol; 1999; 38(6):799-804. PubMed ID: 10522771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Abadi P; Johansen A; Godballe C; Gerke O; Høilund-Carlsen PF; Thomassen A
    Ann Nucl Med; 2017 Feb; 31(2):101-108. PubMed ID: 27921286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion Weighted Imaging Can Distinguish Benign from Malignant Mediastinal Tumors and Mass Lesions: Comparison with Positron Emission Tomography.
    Usuda K; Maeda S; Motono N; Ueno M; Tanaka M; Machida Y; Matoba M; Watanabe N; Tonami H; Ueda Y; Sagawa M
    Asian Pac J Cancer Prev; 2015; 16(15):6469-75. PubMed ID: 26434861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
    Kim YK; Lee KS; Kim BT; Choi JY; Kim H; Kwon OJ; Shim YM; Yi CA; Kim HY; Chung MJ
    Cancer; 2007 Mar; 109(6):1068-77. PubMed ID: 17311309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.